MSK Research Highlights, February 6, 2025
New MSK research reports encouraging results for a new liposarcoma treatment; describes more potent CAR T cells that can be given at lower doses; relates a new way of making drug-delivery nanoparticles more efficient; identifies CAR T cells that activate at the tumor site; and sheds light on how — in very rare cases — a CAR T cell treatment might lead to a new cancer arising.